Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

48.7K
Overview
48.7K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

59
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
59
Cancer Vaccines01:30

Cancer Vaccines

603
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
603
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

908
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
908
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

476
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
476
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

302
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
302

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory bowel diseases in Brazil: journey of doctors who care for patients. What is the importance?

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery·2025
Same author

Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety.

BMC gastroenterology·2025
Same author

Pouchitis unveiled: exploring clinical features, diagnosis, and cutting-edge treatments.

Therapeutic advances in gastroenterology·2025
Same author

Dysplasia and Colorectal Cancer Surveillance in Ulcerative Colitis Patients in Latin America: Real-World Data.

Crohn's & colitis 360·2025
Same author

Dietary Profile of Patients with Inflammatory Bowel Disease in Clinical Remission-A Preliminary Study.

Nutrients·2024
Same author

ARE WE READY FOR MULTIPLE SWITCHES BETWEEN REFERENCE PRODUCTS AND BIOSIMILARS?

Arquivos de gastroenterologia·2024

Related Experiment Video

Updated: Nov 7, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.2K

BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.

Natália Sousa Freitas Queiroz1, Fábio Vieira Teixeira2, Caio Cesar Furtado Freire3

  • 1Departamento de Gastroenterologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brasil.

Arquivos De Gastroenterologia
|April 28, 2021
PubMed
Summary

Mass vaccination is key for COVID-19 pandemic control. This guidance provides recommendations for the safe use of SARS-CoV-2 vaccines in patients with inflammatory bowel disease (IBD).

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.3K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.6K

Related Experiment Videos

Last Updated: Nov 7, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.2K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.3K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.6K

Area of Science:

  • Immunology
  • Gastroenterology
  • Public Health

Background:

  • The COVID-19 pandemic necessitates widespread vaccination.
  • SARS-CoV-2 vaccines are gaining emergency use approval globally.
  • Specific populations, including Inflammatory Bowel Disease (IBD) patients, require tailored vaccine recommendations.

Purpose of the Study:

  • To provide practical advice and key recommendations for COVID-19 vaccination in the IBD population.
  • To address potential concerns regarding SARS-CoV-2 vaccine use in IBD patients.
  • To guide healthcare providers and patients in Brazil regarding vaccine administration.

Main Methods:

  • Review of current scientific literature on COVID-19 vaccines and IBD.
  • Consensus development by the Brazilian IBD Study Group (GEDIIB).
  • Formulation of evidence-based recommendations for IBD patients.

Main Results:

  • Discussion of vaccine safety and efficacy in the context of IBD.
  • Consideration of the impact of IBD therapies on vaccine response.
  • Guidance on prioritizing vaccination for IBD patients.

Conclusions:

  • COVID-19 vaccination is recommended for patients with Inflammatory Bowel Disease.
  • The benefits of SARS-CoV-2 vaccination outweigh potential risks in the IBD population.
  • GEDIIB offers crucial recommendations for managing COVID-19 vaccines in IBD care.